Dare Bioscience
DARE

Dare Bioscience (DARE) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$12.00Dec 2, 2025
Maxim GroupUpgradedHold → Buy$8.00Sep 4, 2025
HC Wainwright & Co.MaintainedBuy$12.00Apr 1, 2025
HC Wainwright & Co.MaintainedBuy$12.00Dec 17, 2024
HC Wainwright & Co.MaintainedBuy$12.00Nov 15, 2024
HC Wainwright & Co.MaintainedBuy$12.00Oct 24, 2024
Jones TradingMaintainedBuy$13.00 from $5.00Aug 16, 2024
Maxim GroupDowngradedBuy → HoldAug 14, 2024
Brookline CapitalUpgradedHold → Buy$3.00May 15, 2024
HC Wainwright & Co.MaintainedBuy$6.00May 15, 2024
HC Wainwright & Co.MaintainedBuy$6.00May 1, 2024
Brookline CapitalDowngradedBuy → HoldApr 17, 2024
HC Wainwright & Co.MaintainedBuy$6.00Apr 1, 2024
HC Wainwright & Co.MaintainedBuy$6.00 from $7.00Nov 10, 2023
HC Wainwright & Co.MaintainedBuy$7.00Aug 11, 2023
HC Wainwright & Co.MaintainedBuy$7.00Jul 13, 2023
HC Wainwright & Co.MaintainedBuy$7.00Jun 6, 2023
HC Wainwright & Co.MaintainedBuy$7.00May 22, 2023
HC Wainwright & Co.MaintainedBuy$7.00May 12, 2023

Frequently asked questions

  • What is the latest analyst rating on DARE?

    On Dec 2, 2025, HC Wainwright & Co. maintained Dare Bioscience at Buy with a price target of $12.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.